The Future of Biopharma: Challenges and Innovations
Kilder
- Statnews: FDA puts off Stoke’s request for faster filing of severe epilepsy drug - statnews.com
- Statnews: Alnylam charts ambitious five-year plan as sales of key drug miss expectations - statnews.com
- Biospace: Biopharma Momentum To Propel Rare Disease, Cancer, Neuro Forward in 2026 - BioSpace
- Biospace: 6 FDA Decisions To Watch in Q1 2026 - BioSpace
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.